Stockreport

Juvisé Pharmaceuticals Formally Approved the Appointments of Frédéric Mascha as Executive Chairman and Chairman of the Supervisory Committee and the Nomination of Renaud Sermondade as the ...

Sanofi - American Depositary Shares  (SNY) 
US:NYSE Investor Relations: sanofi.com/en/investors
PDF April 15, 2026, Juvisé Pharmaceuticals officially acknowledged the resignation of Frédéric Mascha from his role as CEO of the pharmaceutical group and his appointment as [Read more]